SBIR/STTR Research Award
High Throughput Screen for Amadorase Inhibitors
Award amount
$1,000,650Program and phase
SBIR · Phase IIAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- DYNAMIS THERAPEUTICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The goal of this Phase II SBIR proposal is to discover, through high throughput screening (HTS), an orally deliverable drug candidate that inhibits the enzyme fructosamine-3-kinase (F3K). F3K is a promising therapeutic
Technology keywords
Not reported